Herpes Simplex Virus 2 Expresses a Novel Form of ICP34.5, a Major Viral Neurovirulence Factor, through Regulated Alternative Splicing
Herpes Simplex Virus 2 Expresses a Novel Form of ICP34.5, a Major Viral Neurovirulence Factor, through Regulated Alternative Splicing
复制标题
DOI:
10.1128/jvi.03500-12
复制
发表时间:
2013-05-01
影响因子:
5.4
通讯作者:
Krause, Philip R.
中科院分区:
文献类型:
--
作者:
Tang, Shuang;Guo, Nini;Krause, Philip R.
Herpes simplex virus 1 (HSV-1) and HSV-2, two closely related neurotropic human herpesviruses, achieve neurotropism through ICP34.5, a major viral neurovirulence factor. In this report, in addition to the full-length 38-kDa protein (ICP34.5 alpha), we identified a 28-kDa novel form of ICP34.5 (ICP34.5 beta) in HSV-2-infected cells. ICP34.5 beta is translated from unspliced ICP34.5 mRNA, with the retained intron introducing a premature stop codon. Thus, ICP34.5 beta lacks the C-terminal conserved GADD34 domain but includes 19 additional amino acids encoded by the intron. Although a fraction of both HSV-2 ICP34.5 proteins are detected in the nucleolus, ICP34.5 alpha is predominantly located in cytoplasm, and ICP34.5 beta is mainly detected more diffusely in the nucleus. ICP34.5 beta is unable to counteract PKR-mediated eIF2 phosphorylation but does not interfere with ICP34.5 alpha's function in this process. Efficient expression of ICP34.5 beta in cell culture assays is dependent on viral infection or expression of ICP27, a multifunctional immediate-early gene. The effect of ICP27 on the ICP34.5 beta protein level is attributed to its selective inhibition of ICP34.5 splicing, which results in increased expression of ICP34.5 beta but a reduced level of ICP34.5 alpha. The C-terminal KH3 domain but not the RNA binding domain of ICP27 is required for its specific inhibition of ICP34.5 splicing and promotion of ICP34.5 beta expression. Our results suggest that the expression of ICP34.5 alpha and ICP34.5 beta is tightly regulated in HSV-2 and likely contributes to viral pathogenesis.